← Back to Search

Microaggression Impact Assessment for Smoking Behavior

N/A
Recruiting
Led By Brooke Y Kauffman, Ph.D.
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being 18 years of age or older
Current regular (daily) cigarette smoking for >= 1 year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days)
Awards & highlights
No Placebo-Only Group

Summary

This trial examines the correlation between microaggressions and smoking habits, withdrawal symptoms, and cravings. It also investigates whether smoking deprivation affects the relationship between microaggressions and these aspects of smoking behavior.

Who is the study for?
This trial is for Hispanic or Latino adults who smoke at least 5 cigarettes a day, have been smoking regularly for over a year, and have experienced microaggressions in the past 6 months. Participants must be at least 18 years old and able to give informed consent. Those with active suicidal thoughts cannot join.
What is being tested?
The study investigates how experiencing microaggressions might affect smoking behavior, withdrawal symptoms, and cravings among Latinx smokers. It also looks into whether not smoking for a while changes these effects.
What are the potential side effects?
Since this trial involves psychological tasks rather than medical interventions, traditional side effects like those seen with medications are not expected. However, participants may experience stress or discomfort when recalling experiences of racial discrimination.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
You have been smoking cigarettes every day for at least one year.
Select...
You identify yourself as Hispanic or Latino.
Select...
I have experienced at least one microaggression in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the smoking as usual visit and smoking deprivation visit (visits are randomly ordered, counterbalanced separated by ~14 days) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoking Behaviors
Smoking Lapse Behaviors
Subjective Withdrawal
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Smoking as UsualExperimental Treatment1 Intervention
Smoking as usual prior to experimental visit.
Group II: Smoking DeprivationExperimental Treatment1 Intervention
16 hours of smoking abstinence prior to experimental visit.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
151 Previous Clinical Trials
47,843 Total Patients Enrolled
5 Trials studying Smoking
474 Patients Enrolled for Smoking
Brooke Y Kauffman, Ph.D.Principal InvestigatorUniversity of Houston

Media Library

Smoking as Usual Clinical Trial Eligibility Overview. Trial Name: NCT05490927 — N/A
Smoking Research Study Groups: Smoking as Usual, Smoking Deprivation
Smoking Clinical Trial 2023: Smoking as Usual Highlights & Side Effects. Trial Name: NCT05490927 — N/A
Smoking as Usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT05490927 — N/A
Smoking Patient Testimony for trial: Trial Name: NCT05490927 — N/A
~19 spots leftby Jul 2025